Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.140
-0.030 (-2.56%)
At close: Mar 6, 2026, 4:00 PM EST
1.190
+0.050 (4.39%)
After-hours: Mar 6, 2026, 7:55 PM EST
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $2.42 million as of March 6, 2026. Its market cap has decreased by -36.26% in one year.
Market Cap
2.42M
Enterprise Value
2.50M
1-Year Change
-36.26%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $2.42M, a decrease of -80.31%. That is a compound annual growth rate of -21.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.50M | - |
| Dec 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
| Jun 21, 2019 | 12.30M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 2.83M |
| Scinai Immunotherapeutics | 2.81M |
| Enveric Biosciences | 2.75M |
| Jaguar Health | 2.74M |
| Propanc Biopharma | 2.72M |
| 60 Degrees Pharmaceuticals | 2.70M |
| XORTX Therapeutics | 2.55M |
| PMGC Holdings | 2.40M |